Health IT Product News Report June 2022

Allied Market Research reports that the global healthcare information technology (IT) market size was valued at $250,577.15 million in 2020, and is projected to reach $880,688.75 million by 2030, registering a CAGR of 13.3% from 2021 to 2030.

Data Bridge Market Research reports the market drivers and growth can be attributed to the increase in technological know-how, growing volume of patient data, and demand for quick and efficient healthcare processes and systems will help in driving the growth of the healthcare IT market. Increasing digitization in the healthcare industry and demand for value based care and rising cost of provision of healthcare services coupled with the increasing number of healthcare facilities will likely accelerate the growth of the healthcare IT market in the forecast period of 2020-2027.

Health IT

OncoHealth™ Launches New Consumer Platform Bringing Digital Telehealth Services to People with Cancer
OncoHealth, a digital health company dedicated to oncology, unveiled a new digital telehealth service for people with cancer. Iris™ by OncoHealth combines human-centered design, mobile technology, data, empathy, and specially trained oncology experts to deliver personalized, oncology-specific, 24×7 telehealth support to patients and their families facing cancer.

epocrates Unveils Redesigned Mobile App to Streamline Access to Clinician Tools
epocrates (@epocrates), an athenahealth, Inc. company that delivers digital clinical decision support to prescribers, announced the launch of its newly designed mobile app that will streamline access to the wealth of tools clinicians rely on in moments of care and beyond.

Availity Adds Enhanced Claims Status to RESTful API
Availity (@availity), a national real-time health information network announced that Enhanced Claims Status, a multi-payer RESTful API that enriches standard claim status transactions with granular, actionable information, is now available to Availity’s trading partner network.

New Trials App Allows Providers to Recommend Clinical Trials as Therapeutic Option to Patients During Consultations
IllumiCare, a pioneer in point-of-care healthcare information technology, has automated the process of connecting patients to local or hybrid clinical trials during an appointment or consultation through its new Trials App on the Smart Ribbon®.

Biofourmis Selected by American College of Cardiology as Exclusive Virtual Care Platform to Drive TRANSFORM(3) Study Focused on Closing Practice Gaps for Heart Conditions
Biofourmis (@biofourmis), a Boston-based global leader in virtual care and digital medicine, announced that its Biofourmis Care solution has been selected by the American College of Cardiology (ACC) for its TRANSFORM3 study that will evaluate different intervention strategies for improving adherence to guideline-directed medication therapy (GDMT) for managing chronic cardiovascular conditions. The study will place an emphasis on underserved populations and those with a history of healthcare disparities.

ZeOmega Unveils Novel Electronic Prior Authorization Solution
ZeOmega (@zeomega), a population health management organization, announced the launch of its HealthUnity Smart Authorization Gateway (Smart Auth). It is the market’s first and only electronic prior authorization (ePA) solution that comprehensively includes EMR integration capabilities, payer/provider workflows, medical policies integration and adjudication, administrative rules and auto approval rules.

CPSI Pilots Clinical Lens to Ease Provider Data Burdens
CPSI (@cpsiehr), a healthcare solutions company, announced the pilot launch of Quippe Clinical Lens in partnership with Medicomp Systems (@MedicompSys).

Sphere Launches New Payment Solution for Software Vendors Featuring PAX Terminals
Sphere (@SphereCommerce), a provider of end-to-end integrated healthcare payments and security software, announced that it has launched a new payment solution for Independent Software Vendor (ISVs) that features integration with PAX terminals. PAX is the world’s preferred payment terminal solutions provider and has delivered over 60 million terminals to more than 120 countries across the globe.


Let’s Talk Interactive Debuts New Telehealth Solutions at ATA2022
Let’s Talk Interactive (@LetsTalkInter) promoted the launch of TrustVideo, its next-generation enterprise telehealth solution, and IOFX, a new 3D printing and additive manufacturing solution, as well as new service offerings and product innovations.

Pexip Wins “Best Virtual Care Solution”
Pexip (@pexip), a video communication platform, announced it has won “Best Virtual Care Solution” in the sixth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes top companies, technologies, and products in the global health and technology market. In 2021, Pexip was recognized with MedTech’s “Best Telehealth Platform” award.

19Labs announces GALE|Schools, a comprehensive eClinic healthcare solution tailored for schools
As a result of the COVID-19 pandemic, the Federal government is providing funding for school districts to significantly expand the school healthcare services. The 19Labs (@19_labs) GALE tailormade offering for schools builds on the comprehensive GALE eClinic platform, customizing it for the school environment. Beyond traditional telehealth, GALE eClinics enable school nurses to make timely, informed decisions, leveraging the latest smart diagnostic devices remotely and in real-time including stethoscopes, otoscopes, glucometers, and blood pressure cuffs.


RadNet Artificial Intelligence Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI Tools
RadNet, Inc., (@RadNet_Inc) announced that it has received FDA clearances for its DeepHeatlh Saige-DX™ mammography and Quantib® Prostate 2.0 MRI artificial intelligence algorithms. Saige-Dx, a more advanced successor to our FDA approved Saige-Q worklist triage software, is a cancer detection tool that enables radiologists to more effectively detect the presence or absence of breast cancer with the use of artificial intelligence. DeepHealth’s powerful new AI technology automatically identifies suspicious lesions in mammograms and assigns a suspicion level to each finding and to the entire case. It helps detect and diagnose breast cancer earlier while reducing unnecessary recalls.

Artificial Intelligence Company VirtuSense Technologies Announces Fall-Prevention Solution for Senior Living
VirtuSense Technologies (@VirtuSense), an artificial intelligence (AI) solution that detects and prevents falls before they occur, announced that the company’s VSTAlert solution is now available for senior living communities. Leveraging machine vision and an algorithm that learns residents’ habits, VSTAlert can detect high fall-risk residents exiting a bed or chair 30-65 seconds in advance, giving care teams time to intervene before a fall. This fall prevention solution, used primarily in skilled nursing facilities, has reduced patient falls with injury by up to 96%.

AI in Psychiatry – Transforming the Treatment of Mental Disorders
GrayMatters Health (@GraymattersH) is the first to use machine learning technology to create an Electrical-Finger-Print (EFP) of brain-mechanism-specific biomarkers that are utilized in its proprietary treatment of mental disorders, training patients to employ self neuro-modulation techniques using an interactive audio-visual software. This helps patients regain agency over their emotion regulation.

FDA Medical Devices

Approved in April 2022

The FDA regulates medical devices sold in the United States to assure their safety and effectiveness. Medical devices range from simple tongue depressors and hospital gowns to complex programmable pacemakers and robotic surgical systems. Their Medical Device Product Classification database lists over 6,000 types of medical devices regulated by FDA’s Center for Medical Devices and Radiological Health (CDRH) and the classification assigned to each type. Depending on the device classification, along with other factors, federal regulations (such as the Code of Federal Regulations, Title 21) define requirements that must be fulfilled for CDRH to approve or clear devices sold in the United States.

Here are the recently approved devices from April.

FDA Grants Clearance to Perspectum’s CoverScan – A New Platform-Based Tool to Assess Multiple Organs in One MRI Scan
On May 19, 2022, the United States Food and Drug Administration (FDA) granted 510(k) clearance to Perspectum’s (@PerspectumGroup) CoverScan, a noninvasive multiparametric advanced cloud-based software suite that provides comprehensive assessments of six organs, including the heart, liver, lungs, kidneys, pancreas, and spleen. The FDA’s action further solidifies Perspectum as a global leader in the development of medical quantitative assessment technologies.